A novel nonsense mutation in androgen receptor confers resistance to CYP17 inhibitor treatment in prostate cancer

Dong Han(University of Massachusetts Boston), Changmeng Cai(Beth Israel Deaconess Medical Center)
Oncotarget
December 27, 2016
Cited by 12


Related Papers